18F–choline bone biomarkers nuclear medicine positron emission tomography prostate cancer

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
11 Oct 2019
Historique:
received: 10 09 2019
revised: 30 09 2019
accepted: 07 10 2019
entrez: 17 10 2019
pubmed: 17 10 2019
medline: 17 10 2019
Statut: epublish

Résumé

The main aim of this study was to investigate the possible association between

Identifiants

pubmed: 31614564
pii: jcm8101657
doi: 10.3390/jcm8101657
pmc: PMC6832450
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):55-63
pubmed: 20848281
J Nucl Med. 2019 Jul;60(7):971-977
pubmed: 30683768
Future Oncol. 2018 May;14(11):1013-1015
pubmed: 29623724
Bone. 2010 Jul;47(1):140-50
pubmed: 20399290
Nucl Med Biol. 2019 Jan - Feb;68-69:66-79
pubmed: 30770226
Curr Pharm Des. 2015;21(32):4738-47
pubmed: 26283228
Br J Cancer. 2018 Oct;119(9):1129-1132
pubmed: 30327566
CA Cancer J Clin. 2018 Jul;68(4):297-316
pubmed: 29846940
Nucl Med Biol. 2017 Aug;51:40-54
pubmed: 28575697
Contrast Media Mol Imaging. 2018 Dec 9;2018:9840962
pubmed: 30627063
ISRN Oncol. 2011;2011:219064
pubmed: 22220283
Adv Exp Med Biol. 2018;1095:101-110
pubmed: 30229551
Clin Nucl Med. 2013 Jan;38(1):e26-32
pubmed: 23242060
Oncotarget. 2015 Jun 30;6(18):15966-83
pubmed: 25965826
J Mammary Gland Biol Neoplasia. 2018 Jun;23(1-2):89-99
pubmed: 29744755
Per Med. 2018 Nov;15(6):457-459
pubmed: 30398094
J Urol. 2004 Sep;172(3):910-4
pubmed: 15310996
Contrast Media Mol Imaging. 2019 Jul 1;2019:9429761
pubmed: 31354394
Urol Oncol. 2019 May;37(5):297.e19-297.e31
pubmed: 30827759
Biochem Biophys Res Commun. 2019 Mar 5;510(2):296-302
pubmed: 30686531
Semin Urol Oncol. 2002 May;20(2):140-5
pubmed: 12012300
Cell Death Dis. 2017 Oct 12;8(10):e3125
pubmed: 29022895
Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):301-9
pubmed: 19756592
Ann Oncol. 2013 Oct;24 Suppl 7:vii41-47
pubmed: 24001762
Mol Cell Biol. 2004 Aug;24(15):6560-8
pubmed: 15254224
Abdom Imaging. 2015 Oct;40(8):3230-7
pubmed: 26428685
JAMA Oncol. 2017 Apr 1;3(4):524-548
pubmed: 27918777
Pan Afr Med J. 2011;9:20
pubmed: 22355430
BMC Cancer. 2014 Apr 23;14:286
pubmed: 24758513
J Steroid Biochem Mol Biol. 2018 Mar;177:83-90
pubmed: 28887147
Biochim Biophys Acta. 1976 Nov 9;449(2):236-44
pubmed: 10984
Eur Urol. 2008 Aug;54(2):392-401
pubmed: 18456393
Int J Biol Markers. 2014 Dec 09;29(4):e423-30
pubmed: 24474456
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
J Nucl Med. 2015 Feb;56(2):209-15
pubmed: 25552670
Microsc Res Tech. 2018 Jul;81(7):745-748
pubmed: 29633435
PLoS One. 2012;7(7):e41679
pubmed: 22911843
Eur Urol. 2016 Jul;70(1):106-119
pubmed: 26996659
Int J Mol Sci. 2019 Apr 04;20(7):null
pubmed: 30987410
Biochim Biophys Acta Rev Cancer. 2019 Aug;1872(1):138-148
pubmed: 31348975

Auteurs

Nicoletta Urbano (N)

Nuclear Medicine, Policlinico "Tor Vergata", 00133 Rome, Italy. n.urbano@virgilio.it.

Manuel Scimeca (M)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Rome, Italy. manuel.scimeca@uniroma2.it.
Fondazione Umberto Veronesi (FUV), 20122 Milano, Italy. manuel.scimeca@uniroma2.it.

Antonio Crocco (A)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Rome, Italy. crocco.antonio@hotmail.it.

Alessandro Mauriello (A)

Department of Experimental Medicine, University "Tor Vergata", 00133 Rome, Italy. alessandro.mauriello@uniroma2.it.

Elena Bonanno (E)

Department of Experimental Medicine, University "Tor Vergata", 00133 Rome, Italy. elena.bonanno@uniroma2.it.
Neuromed Group, 'Diagnostica Medica' & 'Villa dei Platani', 83100 Avellino, Italy. elena.bonanno@uniroma2.it.

Orazio Schillaci (O)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Rome, Italy. orazio.schillaci@uniroma2.it.
IRCCS Neuromed, 86077 Pozzilli, Italy. orazio.schillaci@uniroma2.it.

Classifications MeSH